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The purpose of this study was to evaluate the usefulness of a 
rnicrodialysis technique for measurement of substances in the 
Interstitial water space in intact human skin. Glucose was 
selected to validate the method. The cutaneous glucose con-
centration was measured by microdialysis and compared to 
that in venous blood. Single dialysis fibers (length 20 mm, 
~,OOO Da molecular weight cutoff) were glued to nylon tub-
lUgs and inserted in forearm skin by means of a fine needle. 
~ialysis fibers were inserted in duplicate. Seven subjects were 
lUvestigated after an overnight fast. Intradermal position of 
the dialysis probes was established by C-mode ultras~und 
scanning. The implantation trauma lasted 90 - 135 mm as 
rneasured by laser Doppler flowmetry. Each dialysis fi?er was 
calibrated in vivo by perfusing it with four to five different 
glucose concentrations. The perfusion rate was 3 Ill/min. 
M easurements pertaining to the i~terstitial water space in skin have generally been ilmlted to analy-sis of samples from suction blisters. However, a method allowing entry to biochemical processes in intact skin would be preferable. Also, the sam-
ples should be caught at the site offormation, thus avoiding dilutio.n 
due to diffusion and enzymatic degradation of the substances. MI-
crodialysis might prove to be such a technique. . . 
tvhcrodialysis has been used for years for the assessment of 111 Situ 
metabolic events at the extracellular level in animal brain prepara-
tions [1,2]. The microdialysis method has only lately been used in 
penpheral tissues, including subcutaneous adipose tissue [3,4] and 
~yocardium [5]. So far, only preliminary results of skin microdialy-
SIS have been published [6]. . 
. The aim of the present study was to elucidate whether the mlcro-~Ialysis method is suitable for measurement of metabolic events in 
uman skin in vivo and to measure the steady-state glucose conce~­
tratlon in skin after an overnight fast. Glucose was selected to '.'111-
date the method because glucose equilibrates rapidly in its distribu-
tion volume. Therefore, comparisons can be made between glucose 
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Regression analysis of the calibration curves yielded the rela-
tive in vivo recovery of glucose. The skin glucose concentra-
tion was calculated as that particular perfusate glucose con-
centration that resulted in no net glucose transport across the 
dialysis membrane. Correlation coefficient of the regression 
lines was 0.93 ± 0.03 (mean ± SEM). After the injection 
trauma had vanished, recovery was 20.5 ± 0.7%. Coefficient 
of variation (CV) on recovery was 10.9%. The cutaneous 
glucose concentration was 99.1 ± 1.8% of the glucose con-
centration in venous plasma water (CV 4.1 %). These find-
ings suggest that the microdialysis technique accurately and 
precisely can reflect biochemical events in the interstitial 
water space in human skin in vivo.] Il1vest DermatoI99:357-
360, 1992 
concentrations in the tissue and venous blood as long as strict 
steady-state conditions are present. 
MATERIALS AND METHODS 
Subjects Seven subjects, one woman and six men, participated in 
the study. One subject was studied on two occasions (see below). 
Mean age was 41 years (range 30 - 60 years). Four of the subjects 
were healthy volunteers and three were patients suffering from 
localized skin diseases. All experiments were performed on normal-
appearing skin. None of the patients took any medication known to 
interfere with carbohydrate metabolism, and none had diabetes 
mellitus. All subjects gave informed consent, and the study was 
approved by the regional Ethical Committee (KF V 100.20~LI/91). 
Skin Microdialysis Technique The probes, ·which are similar 
in principle to a microdialysis probe previously described for subcu-
taneous adipose tissue [3], were constructed by using a single dialysis 
fiber (Gambro GFE 18, Gambro Dialysaten AG, FRG) glued to 
gas-tight nylon tubings with cyanoacrylate and sterilized. The 
fibers (216 11m outer diameter; 811m wall thickness; 2,000 Da mo-
lecular weight cutoff) have a length of 20 mm and the outlet of the 
nylon tubing had a standardized length of 30 mm. 
The inlet of the nylon tubing was connected to a microinjection 
pump (Carnegie CMA/I00, Carnegie Medicin AB, Sweden) and 
perfused with isotonic saline at a rate of 3 111/ min. 
In Vitro Experiments The relative recovery (dialysate/medium 
exchange ratio) of glucose depends on the perfusion rate. Therefore, 
the probe was placed in a vial containing a known glucose concen-
tration. By varying the perfusion rate from 1 to IS l11/min, relative 
recovery was estimated. The results are presented in Fig lA. In the 
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subsequent in vitro studies and in all in vivo experiments, the perfu-
sion rate was 3.uljmin. 
To characterize the dialysis fiber, the probe was positioned in a 
saline solution with different concentrations of glucose. The rela-
tive recovery of glucose in the dialysate was constant (60.5 ± 0.3%, 
mean ± SEM) in the range from 1.0 to 16.5 mM glucose. The 
results are presented in Fig IB. 
The sensitivity of the dialysis probe to record rapid changes in the 
surrounding medium was studied by switching the probe from 16.5 
to 5.0 mM glucose and from 1.0 to 8.2 mM glucose. When 4-min 
samples were collected, 87% of the change in glucose concentration 
was recorded in the dialysate after 4 min, 98% was recognized after 
8 min, and 100% was obtained after 12 min. The results are shown 
in Fig Ie. 
Due to the low perfusion rate, and, with the in vivo experiments, 
the air-exposed inlet and outlet connections, evaporation during the 
sampling procedure might result in an overestimated glucose con-
centration in the dialysate. By using identical glucose concentration 
in the perfusate and in the medium and air-exposed perfused dialysis 
fibers, evaporation was estimated. It was shown that evaporation 
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Figure 1. In vitro recovery of glucose. (A) The dialysis probe was placed in 
a vial containing a 16-mM solution of glucose in saline. Recovery, deter-
mined as the percentage of the glucose concentration in the med'u~ 
mirrored in the dialysate, was assessed with five different perfusion rates ( , 
3,5,10, and 15 J.tl/min). Three Jil/min was chosen as the perfusion rate tn 
the subsequent experiments. (B) The probe was positioned in a v,al,~: 
which the medium contained glucose concentrations ranging from 1-
16.5 mM glucose. The relative recovery was constant in the glucose concen-
tration range tested. (C) The medium was at once changed from 16.5 ~o 
5.0 mM glucose and from 1.0 to 8.2 mM glucose. The time lag of t e 
dialysis probe to record rapid changes in the surrounding medium is shown. 
In all figures, mean ± SEM for three probes are presented. 
during the sampling situation per se was 3.7%. In additio~, .eac~ 
millimeter of air-exposed dialysis probe resulted in an addltl°fa_ 
0.4% evaporation of the dialysate. Therefore, in vitro dialysate g u 
cose concentrations (including the above-mentioned results) were 
divided by a factor of 1.037. As the length of the air-exposed dialrs's 
fiber was 1-2 mm on both the inlet and outlet connection, in VI;O 
dialysate glucose concentrations were divided by a factor of 1.0 . 
In Vivo Experiments By use of a 23-gauge cannula, the dialysi~ 
probes were placed most superficially in the skin on the :,entrall~rr 
of the forearm 10 cm below the cubital region. The dlalys,s ~e 
was led through the cannula, the cannula was withdrawn, and t 
outle.t tubing was positioned and glued. By gluing the outlet tub'~~ 
after implantation, the size of the cannula could be reduced from he 
gauge to 23 gauge. The length of the dialysis fiber positione~ ~n t d 
skin was 20 mm. Two adjacent dialysis fibers were POSltlond. 30 mm apart. In one subject, a single dialysis probe was impl~nte s~ 
in two subjects three probes were inserted. The subjects were ,"ve
r
_ 
tigated in the supine position and the measurements were pem 
formed after an . overnight fast . In some subjects, EMLA crea 
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(Astra) and Tegaderm (3M) occlusion were applied 30 min before 
the Implantation. Venous blood samples were drawn from the con-
tralateral cubital vein. 
In order to ensure the intracutaneous position of the dialysis 
probes, ultrasound scannings were performed. A 20-MHz scanner 
(Dermascan C, Cortex Technology, Denmark) was used. The ul-
trasound velocity was 1580 m/second. 
Hyperemia caused by the probe implantation was measured by 
lase.r Doppler flowmetry (PEl, Perimed, Sweden). Upper frequency 
lImit was 12 kHz; time constant was 10 seconds. 
In Vivo Calibration It has been shown that in vivo recovery 
~oes not correspond to in vitro recovery as mass transport in the 
tissues differs from that in aqueous solutions [3,7]. Lonnroth et al [3] 
presented an in vivo calibration technique that allows estimation of 
the exact in vivo recovery. The glucose concentration in the dialy-
Sate mirrors the recovery of the glucose gradient by the dialysis 
membrane. Because the recovery of glucose was constant over a 
~Ide range of glucose concentrations, a linear relationship is estab-
lIshed in the dialysate and the concentration gradient over the dialy-
SIS membrane. If, then, the dialysis probe is perfused with different 
concentrations of glucose, a linear relationship is established be-
tween the net increase of the glucose concentration in the dialysate 
and the concentration of glucose in the inlet of the tubing. By using 
regression analysis, the concentration of glucose in the perfusate not 
resulting in any net influx of glucose can be calculated. At this 
~lucose concentration, the gradient across the dialyzing membrane 
IS zero; thus, the glucose concentration is in equilibrium with that of 
the surrounding tissue. Mean recovery of glucose is obtained from 
~he slope of the regression line. The linear regression analysis was 
ased on four to five different glucose concentrations (ranging from 
0.6-7 mM glucose) using the least-squares method. The different 
glucose concentrations were used in a random order. 
. In two subjects, the experiments were initiated immediately after 
Implantation of the probes. In four subjects, the experiments were 
nOt performed until the injection trauma had vanished, i.e., at least 
~ h after implantation. In two subjects, the calibration was per-
ormed 18 h after implantation. One person was studied on two 
occaSIOns (different probes were tested, during the implantation 
trauma phase and 18 h after implantation, respectively). 
Glucose Analysis Glucose concentrations in dialysate and 
~lasma were measured using the glucose oxidase method [8] on a 
eckmann Glucose Analyzer (Beckman Instruments, Fullerton, 
CAl . The glucose concentration in plasma water was calculated as 
106.% of the glucose concentration of the plasma glucose concen-
tration, assuming the plasma protein concentration to be 60 gil. 
RESULTS 
Without local analgesia, the probe implantation procedure caused a 
~oderate, short-term discomfort. No pain was registered after ap-
p Ication of EM LA cream. 
t The traumatic hypermia had vanished 90 - 135 min after implan-
atlon as measured by laser Doppler flowmetry (data not shown). In 
tnost subjects, the post-implantation baseline was similar to the 
pre-Implantation baseline value. . 
£ C-mode ultrasound scanning of the probe position was per-
o~rned on seven fibers, all of which were positioned in the dermis 
~Ithout detours into the underlying subcutaneous tissue. The scan-
ning a~paratus was unavailable during most of the experiments . 
. The 111 vivo calibration procedure based on perfusion of the dialy-
SIS probe with different concentrations of glucose was used to esti-
kate in vivo recovery and absolute glucose concentrations in the 
s In. An example is presented in Fig 2. 
SE,The r value of the regression lines was 0.93 ± 0.03 (mean ± 
th M.). Three fibers had r values below 0.8 (range 0.65-0.74). If 
o gese fibers were not taken into consideration, mean r value was 
. 7 ± 0.01. 
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Figure 2. An in vivo calibration is shown. For further details, refer to 
Materials atld Methods. In this example, data from rwo fibers (represented by 
opel! and solid circles, respectively) are shown. Both coefficients of correla-
tion were 0.998. Recovery was 20.5 and 23.0%, respectively. The skin 
glucose level (5.3 and 5.2 mM) was identical with that in venous plasma 
water (5.3 mM). The expenment was performed after the implantation 
trauma had vanished. 
During the implantation trauma phase, recovery was 32.3 ± 
0.1%. After the trauma had vanished, recovery was 19.9 ± 1.3%, 
and 18 h after implantation recovery was 21.6 ± 0.6%. For the 
entire post-trauma period, recovery was 20.5 ± 0.7%. The coeffi-
cient of variation on adjacent fibers on recovery was 10.9%. 
The skin glucose concentration was 99.1 ± 1.8% of the glucose 
concentration 111 venous plasma water. If only fibers with r values 
greater than 0.8 were taken into consideration, the skin/plasma 
glucose ratio was 98.3 ± ~.6%. The coefficient of variation on adja-
cent fibers on the estimation of the skin glucose concentration was 
4.1%. 
Control measurements were performed to investigate whether 
the decl111e 111 recovery from the time of implantation and after-
wards was irreversible, for instance, caused by plugging the pores of 
the dialySIS membrane with dermal proteins. 
Six di.alysis fibers were implanted in two fasting healthy subjects 
~s descnbed above. The experiments were performed 2-3 h after 
111SertiOn of the fibers . A steady-state perfusion baseline was ob-
tained for 20 min. Then the skin above each fiber was epicu-
ta~eously challenged with histamine chloride 16 mg/ml. Three 
pnck tests were performed along each fiber in order to ensure that 
the entire fiber was covered by wheals. Glucose was collected in 
30-,u1 (10 min) fractions. The results are shown in Table I. The 
dialysate glucose concentrations following skin-prick testing are 
presented relative to baseline values. The glucose concentration 
increased about 100% following histamine challenge. In all cases, 
the entire fiber was covered by wheals. 
Table I. Changes in Dialysate Glucose Concentrations After 
Induction of Skin Inflammation" 
Baseline 
100% 
0-10 min 
146 ± 5% 
10 - 20 min 
194 ± 9% 
20 - 30 min 
174±11% 
30-40 min 
165 ± 15% 
II At time zero, the skin above each fiber was challenged with histamine. Values are 
mean ± SEM of six fibers implanted in two fasting subjects. 
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In all subjects, the entire fiber material was removed after the 
experiments. 
DISCUSSION 
The present study demonstrates for the first time the usefulness of 
the micro dialysis technique for quantitative characterization of 
s~bstances in the intercellular water space in intact human skin in 
VIVO . 
We found skin glucose levels identical to those in venous plasma 
water. However, we ignored the interstitial protein content, which 
probably is 7 - 25 gil [10]. Thereby we may have underestimated 
the glucose concentration in the skin by 0.7-2.5%. Our results 
support the concept that glucose is not concentrated in the skin as 
previously considered {[9] for review}. 
The microdialysis technique opens up possibilities for evaluation 
of metabolic processes in intact human skin. In contrast to blister 
models, the epidermal-dermal interaction is preserved, the tech-
nique reflects in situ biochemical processes, and enzymatic degrada-
tion of the samples is minimized. However, several conditions must 
be taken into consideration. Drainage of substances from the tissue 
must be prevented or minimized, and the dialysis surface area prone 
to diffusion must be constant throughout the experiments. In other 
applications, it has been demonstrated that microdialysis probes can 
drain glucose [3]. calcium [7], and other substances from the' tissue. 
Recently, Hickner et al [11] showed that the glucose concentration 
in the dialysate increased and decreased parallel with changing mus-
cle blood flow. The authors suggest that increased blood flow coun-
teracts local drainage of glucose, and decreased blood flow expedites 
glucose drainage. Changes in blood flow per se appear to have no 
influence on recovery [12]. 
In our experiments, we used perfusates with glucose in order to 
avoid drainage. Our finding that the calibration technique esti-
mated the skin glucose concentration to be similar to plasma glucose 
concentration, both during the implantation trauma period and 
after the trauma had vanished, suggest that no drainage of glucose 
took place in the skin in our experiments. Control measurements 
showed that recovery of glucose was constant for at least 2 h even 
without glucose added to the perfusate {unpublished observations}. 
Therefore, drainage of glucose seems to be no problem in normal 
skin during short-term measurements. 
Additionally, one must make sure that the dialysis capacity of the 
fiber is constant throughout the experiment. However, it was dem-
onstrated that the recovery was variable. During the implantation 
trauma, recovery was about 50% greater than after the trauma had 
vanished. Control measurements with histamine skin-prick tests 
showed that the dialysate glucose concentration increased by 100% 
during the wheal reaction. Assuming that no concentration of glu-
cose took place in the skin during the hyperemia, the increased 
dialysate glucose concentration must be caused by increased recov-
ery of glucose. Consequently, we postulate that increased recovery 
during the implantation trauma phase was caused by trauma-in-
duced vascular leakage, plasma extravasation, and edema formation, 
creating an increased probe surface area prone to diffusion. After the 
trauma had vanished, recovery was constant for at least 16 h. 
In our set-up, 24 - 36,u1 was needed to establish a new steady state 
of recovery after acute changes in glucose concentrations in the 
medium. This time resolution might limit the use of the microdia-
lysis technique for some clinical research involving acute-phase reac-
tions . However, the time resolution depends on the perfusion rate, 
the substances studied, and the analytical technique. We suppose 
that the microdialysis technique can be modified for use in many 
branches of dermatologic research . 
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EMLA cream was used to avoid discomfort during implantation. 
Control measurements performed 2 h after removal of the EMLA 
cream suggest that the analgetic effect had vanished at that time. 
Skin sensitivity to needles and histamine skin-prick test-induced 
flare reactions on the treated skin areas were comparable to values 
on untreated skin. The short-lasting action of EMLA cream in our 
application might be explained by an increased elimination rate of 
the analgetic substances due to skin hyperemia. In other types of 
experiments, further control studies are needed in order to exclude 
interference from the EMLA cream. 
The in vivo calibration procedure is time consuming and is suit-
able only for steady-state conditions. On the other hand, se~~­
quantitative microdialysis seems to possess a broad range of possibIlI-
ties. As the coefficient of variation on recovery was acceptable, 
comparisons between dialysis probes are feasible without in VIVO 
calibration. 
On the basis of the present observations, we conclude that skin 
microdialysis might be a valuable tool in dermatologic research. 
We thank Dr.Jergen Semp Jar tec/mical assistatlce with the II/trasal/tld scatwi/if:.. 
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